Search Within

Melanoma Disease Management Team

Formats
  1. Journal Article (1603)
  2. Meeting Abstract (789)
  3. Book Section (104)
  4. Review (71)
  5. Editorial (58)
  6. Research Letter (45)
  7. Guidelines (26)
  8. Conference Paper (22)
  9. Correspondence (21)
  10. Miscellaneous (16)
  11. Book Whole (11)
Groups
  1. Department of Medicine (1688)
  2. Survivorship Research (1191)
  3. Solid Tumor Oncology Division (1051)
  4. Department of Pathology and Laboratory Medicine (953)
  5. Surgery (946)
  6. Melanoma and Immunotherapeutics Service (793)

More Groups

People
  1. Klaus Busam (696)
  2. Daniel Coit (543)
  3. Allan Halpern (400)
  4. Michael Postow (369)
  5. Alexander Shoushtari (247)
  6. Jedd Wolchok (222)

More People

Years
  1. 2025 (85)
  2. 2024 (138)
  3. 2023 (160)
  4. 2022 (167)
  5. 2021 (149)
  6. 2020 (142)

More Years

Publications
  1. Journal of Clinical Oncology (269)
  2. Annals of Surgical Oncology (221)
  3. Journal of the American Academy of Dermatology (123)
  4. Journal of Investigative Dermatology (83)
  5. Modern Pathology (67)
  6. American Journal of Surgical Pathology (64)

More Publications

Publishers
  1. Springer (341)
  2. American Society of Clinical Oncology (284)
  3. Elsevier Inc. (231)
  4. Lippincott Williams & Wilkins (229)
  5. Wiley Blackwell (162)
  6. Elsevier Science, Inc. (159)

More Publishers

Results (2766)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Metastatic melanoma mimicking blue nevus
    Meeting Abstract

    Busam, K. J.
    Laboratory Investigation (1998)

    Fulltext@MSK | Save
  • Immunoreactivity for A103, an antibody to Melan-A (MART-1), in primary cutaneous melanomas and benign melanocytic nevi
    Meeting Abstract

    Busam, K. J.; Iversen, K.; Coplan, K. A.; Old, L. J.; Stockert, E.; Chen, Y. T.; Barnhill, R. L.; Jungbluth, A.
    Laboratory Investigation (1998)

    Fulltext@MSK | Save
  • Prognostic significance of combined detection of tyrosinase and GAGE mRNAs in the peripheral blood (PB) and bone marrow (BM) of patients with malignant melanoma (MM)
    Meeting Abstract

    Ghossein, R.; Cheung, I.; Venkatraman, E.; Coit, D.; Rosai, J.
    Laboratory Investigation (1998)

    Fulltext@MSK | Save
  • Hodgkin's panniculitis
    Meeting Abstract

    King, R.; Busam, K.
    Laboratory Investigation (1998)

    Fulltext@MSK | Save
  • Angiomyolipomas express antigen as well as mRNA of melanocytic markers gp-100 and melan-A/MART-1
    Meeting Abstract

    Jungbluth, A. A.; Busam, K. J.; Iversen, K.; Coplan, K.; Williamson, B.; Stockert, E.; Chen, Y. T.; Old, L. J.
    Modern Pathology (1998)

    Fulltext@MSK | Save
  • Immunoreactivity for A103, an antibody to Melan-A (MART-1), in primary cutaneous melanomas and benign melanocytic nevi
    Meeting Abstract

    Busam, K. J.; Iversen, K.; Coplan, K. A.; Old, L. J.; Stockert, E.; Chen, Y. T.; Barnhill, R. L.; Jungbluth, A.
    Modern Pathology (1998)

    Fulltext@MSK | Save
  • Metastatic melanoma mimicking blue nevus
    Meeting Abstract

    Busam, K. J.
    Modern Pathology (1998)

    Fulltext@MSK | Save
  • Prognostic significance of combined detection of tyrosinase and GAGE mRNAs in the peripheral blood (PB) and bone marrow (BM) of patients with malignant melanoma (MM)
    Meeting Abstract

    Ghossein, R.; Cheung, I.; Cheung, N. K.; Venkatraman, E.; Coit, D.; Rosai, J.
    Modern Pathology (1998)

    Fulltext@MSK | Save
  • Hodgkin's panniculitis
    Meeting Abstract

    King, R.; Busam, K.
    Modern Pathology (1998)

    Fulltext@MSK | Save
  • External validity of a melanoma prognostic model
    Meeting Abstract

    Margolis, D. J.; Halpern, A. C.; Rebbeck, T.; Berwick, M.
    Journal of Investigative Dermatology (1998)

    Fulltext@MSK | Save